You just read:

EMA Grants Orphan Drug Designation to Debiopharm International SA's FGFR Inhibitor Debio 1347 in the Treatment of Biliary Tract Cancer

News provided by

Debiopharm International SA

14 Nov, 2017, 08:00 GMT